Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis

被引：0
|
作者：
Osvaldo Artigalás
Tazio Vanni
Mara Helena Hutz
Patricia Ashton-Prolla
Ida Vanessa Schwartz
机构：
[1] UFRGS,Postgraduate Program in Genetics and Molecular Biology, Department of Genetics
[2] Grupo Hospitalar Conceição,Genetics Unit, Children’s Hospital
[3] GHC,Coordenação Geral de Avaliação de Tecnologias em Saúde – CGATS, Department of Science and Technology
[4] Ministry of Health,undefined
[5] Medical Genetics Service,undefined
[6] Hospital de Clinicas de Porto Alegre,undefined
[7] HCPA,undefined
来源：
BMC Medicine | / 13卷
关键词：
Adverse effects; Aromatase inhibitors; Breast cancer; Clinical outcomes; Meta-analysis; Pharmacogenetics; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis
    Artigalas, Osvaldo
    Vanni, Tazio
    Hutz, Mara Helena
    Ashton-Prolla, Patricia
    Schwartz, Ida Vanessa
    [J]. BMC MEDICINE, 2015, 13
  • [2] Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients
    Roberta Ferraldeschi
    Monica Arnedos
    Kristen D. Hadfield
    Roger A’Hern
    Suzie Drury
    Andrew Wardley
    Anthony Howell
    D. Gareth Evans
    Stephen A. Roberts
    Ian Smith
    William G. Newman
    Mitch Dowsett
    [J]. Breast Cancer Research and Treatment, 2012, 133 : 1191 - 1198
  • [3] Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients
    Ferraldeschi, Roberta
    Arnedos, Monica
    Hadfield, Kristen D.
    A'Hern, Roger
    Drury, Suzie
    Wardley, Andrew
    Howell, Anthony
    Evans, D. Gareth
    Roberts, Stephen A.
    Smith, Ian
    Newman, William G.
    Dowsett, Mitch
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 1191 - 1198
  • [4] Polymorphisms of the aromatase gene (CYP19A1) and benefit of aromatase inhibitors (AIs) in metastatic breast cancer (mBC) patients
    Arnedos, M.
    Ferraldeschi, R.
    A'Hern, R.
    Hadfield, K.
    Roberts, S.
    Drury, S.
    Howell, A.
    Evans, D. G.
    Wardley, A. M.
    Smith, I. E.
    Newman, W. G.
    Dowsett, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Relationship between polymorphisms of CYP19A1 gene and hypertension: a meta-analysis
    Meng, Yajie
    Adi, Dilare
    Wang, Ting
    Dong, Chunlan
    Wang, Bei
    Abudoukelimu, Mayila
    Liu, Fen
    Chen, Bangdang
    Fu, Zhenyan
    Ma, Yitong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 1953 - 1966
  • [6] Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
    Mao, Jun J.
    Su, H. Irene
    Feng, Rui
    Donelson, Michelle L.
    Aplenc, Richard
    Rebbeck, Timothy R.
    Stanczyk, Frank
    DeMichele, Angela
    [J]. BREAST CANCER RESEARCH, 2011, 13 (01):
  • [7] RESEARCH ON AROMATASE GENE (CYP19A1) POLYMORPHISMS AS A PREDICTOR OF ENDOCRINE THERAPY EFFECTIVENESS IN BREAST CANCER
    Miron, L.
    Negura, L.
    Peptanariu, D.
    Marinca, M.
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (04): : 997 - 1004
  • [8] The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis
    Xing, Chuan
    Zhao, Han
    Zhang, Jiaqi
    He, Bing
    [J]. FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [9] Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
    Jun J Mao
    H Irene Su
    Rui Feng
    Michelle L Donelson
    Richard Aplenc
    Timothy R Rebbeck
    Frank Stanczyk
    Angela DeMichele
    [J]. Breast Cancer Research, 13
  • [10] Role of CYP2E1 polymorphisms in breast cancer: a systematic review and meta-analysis
    Yu Lu
    Xuan Zhu
    Cuiping Zhang
    Kongmei Jiang
    Chunni Huang
    Xue Qin
    [J]. Cancer Cell International, 17
12345